Tretinopak (PureTek Corporation)
Welcome to the PulseAid listing for the Tretinopak drug offered from PureTek Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | PureTek Corporation |
NON-PROPRIETARY NAME: | tretinoin, avobenzone, octinoxate, octisalate and titanium dioxide |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2017-03-06 |
END MARKETING DATE: | 0000-00-00 |
Tretinopak HUMAN PRESCRIPTION DRUG Details:
Item Description | Tretinopak from PureTek Corporation |
LABELER NAME: | PureTek Corporation |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2017-03-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 59088-800_084b1719-5104-4e8a-9f32-1542a11f07f5 |
PRODUCT NDC: | 59088-800 |
APPLICATION NUMBER: | NDA020404 |